Skip to content

Immediate Post-Operative Anesthesia With Either Lidocaine or Bupivacaine

Immediate Post-Operative Anesthesia With Either Lidocaine or Bupivacaine: A Short-term Clinical Response

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06293807
Enrollment
72
Registered
2024-03-05
Start date
2022-06-06
Completion date
2023-04-16
Last updated
2024-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Diseases

Keywords

Flap debridement, Flap osseous, Tooth extractions, Guided Tissue Regeneration, IV sedation, Local anesthesia

Brief summary

Immediate post-suturing administration of either one of two dental anesthetic solutions or a placebo prior to dismissal.

Detailed description

This study seeks to evaluate the pain response following the administration of two anesthetic solutions just prior to patient dismissal from a surgical procedure: 2% Xylocaine with 1:100,000 epi and 0.5% Bupivicaine with 1:200,000 epi in comparison with 0.9% Normal Saline as a placebo. the study team will monitor pain response following these interventions at 4, 8, 12, 24, and 48 hours.

Interventions

DRUGXylocaine 2 % with 1:100,000 epinephrine

Local anesthetic used during dental procedures

DRUGBupivicaine 0.5% with 1:200,000 epinephrine

Local anesthetic used during dental procedures

OTHERPlacebo

0.9% Normal Saline solution used in place of local anesthetic

Sponsors

The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Both the surgeon and patient will be blinded as to the intervention provided by covering identifying marks of the anesthetic carpules to be administered. Randomization will be assured by random selection of a slip of paper drawn from a sealed envelope assigning the patient to one of three groups.

Intervention model description

A randomized, placebo-controlled, parallel design study.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

-Patients who have undergone a comprehensive periodontal evaluation and treatment plan not related to participation in this study and… 1. require flap surgery of 2 to 5 teeth in a continuous site (including flap debridement, flap osseous, extractions, and Guided Tissue Regeneration (GTR) procedures), and… 2. require IV sedation and local anesthesia or local anesthesia only… 3. in either the maxillary or mandibular arch.

Exclusion criteria

1. Pregnancy, or those planning to become pregnant 2. allergy or any medical issue using Lidocaine or Bupivacaine 3. inability to take non-steroidal anti-inflammatory drugs (NSAIDS) or acetaminophen 4. non-English speaking 5. not possessing an I-phone or Android device 6. patients requiring narcotic for IV sedation 7. patients requiring either IV or oral steroids during the perioperative period

Design outcomes

Primary

MeasureTime frameDescription
Change in pain using Visual Analog Scale (VAS)Baseline to 48 hoursPain response recorded using a 20 point visual Analog Scale. The VAS scale is a straight line scale scored from 0-20 with 0 indicating the least amount of pain and 20 the worst pain ever experienced.
Number of Ibuprofen administeredBaseline to 48 hoursAdditive number of ibuprofen taken over monitoring period
Number of Tylenol administeredBaseline to 48 hoursAdditive number of acetaminophen taken over monitoring period

Secondary

MeasureTime frameDescription
Gender of patientBaseline to 48 hoursDifference in pain response based upon gender of participant
Arch ResponseBaseline to 48 hoursDifference in pain response based upon arch
Age of patientBaseline to 48 hoursDifference in pain response based upon age of participant
Number of teethBaseline to 48 hoursDifference in pain response based upon number of teeth per surgical site
Type of procedureBaseline to 48 hoursDifference in pain response based upon type of procedure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026